In the landscape of biochemical research, few tools have proven as essential for studying cellular signaling pathways as the thrombin receptor activating peptide 6. Functional Selectivity of G Protein Signaling by Agonist Often referred to as TRAP-6, this synthetic hexapeptide has become a cornerstone in laboratory settings for those investigating the mechanisms of protease-activated receptors. As someone who follows advancements in peptide science, I have found the technical precision of this compound to be a fascinating subject of study.
What is Thrombin Re Thrombincleaves its G-protein-linked seven-transmembrane domainreceptor, thereby releasing a 41-aapeptideand generating a new amino terminus that acts Read more ceptor Activating Peptide 6?
Thrombin receptor activating peptide 6 (CAS# 141136-83-6) is a synthetic peptide that mimics the N-terminal sequence of the tethered ligand formed after thrombin cleavage of the PAR-1 receptor. Specifically, it corresponds to residues 42-47 of the protease-activated receptor-1 (PAR-1). Because TRAP-6 acts as a potent PAR-1 agonist, it allows researchers to bypass the need for enzymatic cleavage to trigger receptor responses.
The molecular structure, with an empirical formula of C34H56N10O9 and a molecular weight of 748.9, is designed to interact specifically with the thrombin receptor. Unlike natural processes that involve the complex cleavage of the thrombin receptor's amino terminus, TRAP-6 provides a clean, independent method of stimulation.
Key Applications and Research Utility
T TRAP-6 (PAR-1 agonist peptide) he primary utility of this peptide lies in its ability to serve as a reliable tool for platelet activation. In many experimental models, TRAP-6 has been shown to selectively activate PAR1 while demonstrating no significant activity at PAR4. This selectivity is vital for researchers aiming to isolate specific signaling pathways.
In Vitro Platelet Studies
One of the most common applications I have observed is that TRAP-6 has been used to activate platelets in vitro. By providing a stable, synthetic alternative to bovine thrombin, it enables standardized testing of platelet function. It is frequently employed in studies where platelet activation triggers glycoprotein VI (GPVI) dimerization, allowing for a clearer understanding of th by RM Scarborough·1992·Cited by 389—In this report we define the structural features of thethrombin receptor'sagonistpeptidedomain important forreceptor activation.Read more e molecular cascade involved in these processes.
Beyond Platelet Aggregation
While its role in inducing aggregation is well-documented, the scope of TRAP-6 research is expanding. For instance, Thrombin Receptor Activator Peptide 6 (TRAP-6) protects certain cell types, such as astrocytes, from specific stressors. Furthermore, recent studies have explored how thrombin receptor-activating peptide-6 (TRAP-6) can influence immune responses, such as decreasing acute graft-versus-host disease in mouse models, an effect linked to GPR15 expression.
Technical Specifications and Performance
When sourcing materials for research, purity is paramount. Most high-quality thrombin receptor activator peptide 6 preparations boast a purity of >95% via HPLC. The thrombin receptor agonist peptide-6 SFLLRN is the specific amino acid sequence that de TRAP-6 activates human platelets via the thrombin receptor. TRAP-6 shows no activity at PAR4 . TRAP-6 Read more fines its potency.
It is important to note that TRAP-6 is a synthetic hexapeptide that activates the thrombin receptor without triggering the formation of fibrin, making it a "clean" agonist. Whether you are using it as a positive control in a PRP (platelet-rich plasma) assay or investigating the downstream effects of activated recept Thrombin Receptor Activator Peptide6 ors, the consistency of this compound is its greatest asset.
Summary of Findings
The evolution of thrombin receptor-activating peptides (TRAPs) has provided the scientific community with an invaluable resource. From its origins as a mimic of the tethered ligand to its current use in complex cellular studies, TRAP-6 remains an indispensable tool.
Key takeaways for researchers include:
* Selectivity: It specifically targets PAR-1, making it distinct from other thrombin-mediated pathways.
* Consistency: As a synthetic peptide, it offers reproducible results, especially when Thrombin receptor-activating peptides (TRAPs) compared to the variability of natural thrombin.
* Versatility: Its application ranges from basic platelet aggregation assays to advanced studies on neuroprotection and immune modulation.
By leveraging the precise nature of Thrombin Receptor Activator for Peptide 6 (TRAP-6), researchers can continue to map the intricate signaling ne Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.Read more tworks of thrombin and its associated activated receptors. As we continue to refine our methods, the role of these synthetic fragments in understanding biological mechanisms will undoubtedly grow.